Matthew E. Layton

Brain elimination half-life of fluvoxamine measured by 19F magnetic resonance spectroscopy.

S. Dager, M. Layton, W. Strauss, 1998, The American journal of psychiatry.

19F magnetic resonance spectroscopy investigation in vivo of acute and steady-state brain fluvoxamine levels in obsessive-compulsive disorder.

S. Dager, M. Layton, W. Strauss, 1997, The American journal of psychiatry.

Two-dimensional proton echo-planar spectroscopic imaging of brain metabolic changes during lactate-induced panic.

S. Posse, T. Richards, S. Dager, 1999, Archives of general psychiatry.

Human brain metabolic response to caffeine and the effects of tolerance.

S. Posse, T. Richards, S. Dager, 1999, The American journal of psychiatry.